Kit is a growth factor receptor that regulates proliferation and/or survival of many embryonic and postnatal stem cell types. When mutated, it can induce malignant transformation of the host cells. To dissect the Kit role in the control of ESC pluripotency, we studied its expression during early mouse embryogenesis and during the process of ESC derivation from inner cell mass (ICM) cells. We followed the in vitro development of early mouse embryos obtained from transgenic mice carrying Kit promoter regions fused to EGFP (Kit-EGFP) and found that they initiate EGFP expression at morula stage. EGFP expression is then maintained in the blastocyst, within the ICM, and its levels increase when cultured in the presence of MAPK and GSK3β inhibitors (2i) plus LIF compared with the LIF-only condition. Kit-EGFP ESCs showed nonhomogeneous EGFP expression pattern when cultured in LIF condition, but they upregulated EGFP expression, as well as that of Sox2, Nanog, Prdm14, when shifted to 2i-LIF culture. Similarly, primordial germ cells (PGCs) in the process of embryonic germ cell (EGC) conversion showed enhanced EGFP expression in 2i-LIF. Kit expression was affected by manipulating Sox2 levels in ESCs. Chromatin immunoprecipitation experiments confirmed that Sox2 binds Kit regulatory regions containing Sox2 consensus sequences. Finally, Kit constitutive activation induced by the D814Y mutation increased ESC proliferation and cloning efficiency in vitro and in teratoma assays in vivo. Our results identify Kit as a pluripotency-responsive gene and suggest a role for Kit in the regulation of ESC proliferation. STEM CELLS 2019;37:332-344
SIGNIFICANCE STATEMENTBy exploiting transgenic mice carrying Kit different promoter regions fused to EGFP (Kit-EGFP) it was found that embryos initiate EGFP expression at morula stage. EGFP expression is then maintained in the blastocyst, within the ICM, and more importantly, its levels along with those of Kit increase in ground state culture conditions (MAPK and GSK3β inhibitors [2i] and LIF) compared with standard conditions (LIF only). Indeed, it was found that ESCs upregulated EGFP expression, as well as that of Sox2, Nanog, Prdm14 but not Oct4 in 2i-LIF, whereas they showed a nonhomogeneous EGFP expression pattern when cultured in LIF only condition. It was found that primordial germ cells, that share a similar transcriptional profile with ESCs, are sensitive to ground state culture conditions during the transition to EGC state. It was also found that Sox2 controls Kit and EGFP expression in ESCs. Finally, by producing a constitutive active Kit allele, it was found that mutant ESCs impaired early embryo development following their injection in host blastocyst and showed increased proliferation rate in vitro and in teratoma assays in vivo. The results show that Kit regulatory regions respond to ground state culture conditions and suggest a role of Kit in the regulation of ESC proliferation.